Cargando…

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein

A licensed vaccine for respiratory syncytial virus (RSV) is unavailable, and passive prophylaxis with the antibody palivizumab is restricted to high-risk infants. Recently isolated antibodies 5C4 and D25 are substantially more potent than palivizumab, and a derivative of D25 is in clinical trials. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Daiyin, Battles, Michael B., Moin, Syed M., Chen, Man, Modjarrad, Kayvon, Kumar, Azad, Kanekiyo, Masaru, Graepel, Kevin W., Taher, Noor M., Hotard, Anne L., Moore, Martin L., Zhao, Min, Zheng, Zi-Zheng, Xia, Ning-Shao, McLellan, Jason S., Graham, Barney S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707411/ https://www.ncbi.nlm.nih.gov/pubmed/29187732 http://dx.doi.org/10.1038/s41467-017-01858-w

Ejemplares similares

Respiratory syncytial virus entry and how to block it
por: Battles, Michael B., et al.
Publicado: (2019)

Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus
por: Killikelly, April M., et al.
Publicado: (2016)

Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
por: Rossey, Iebe, et al.
Publicado: (2017)

Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein
por: Battles, Michael B., et al.
Publicado: (2017)

Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
por: Rossey, Iebe, et al.
Publicado: (2017)

Structural Basis for Binding of Neutralizing Antibodies to Clostridioides difficile Binary Toxin
por: Goldsmith, Jory A., et al.
Publicado: (2023)

An Overview of Respiratory Syncytial Virus
por: Meng, Jia, et al.
Publicado: (2014)

WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015
por: Modjarrad, Kayvon, et al.
Publicado: (2016)

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
por: Wrapp, Daniel, et al.
Publicado: (2020)

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
por: Wrapp, Daniel, et al.
Publicado: (2020)

A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus
por: Stewart-Jones, Guillaume B. E., et al.
Publicado: (2015)

Structural basis for antibody binding to adenylate cyclase toxin reveals RTX linkers as neutralization-sensitive epitopes
por: Goldsmith, Jory A., et al.
Publicado: (2021)

Treatment strategies for Middle East respiratory syndrome coronavirus
por: Modjarrad, Kayvon
Publicado: (2016)

MERS-CoV vaccine candidates in development: The current landscape
por: Modjarrad, Kayvon
Publicado: (2016)

A mechanistic basis for potent, glycoprotein B-directed gammaherpesvirus neutralization
por: Glauser, Daniel L., et al.
Publicado: (2011)

Structural basis for ultrapotent antibody-mediated neutralization of human metapneumovirus
por: Banerjee, Avik, et al.
Publicado: (2022)

Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B
por: Joyce, M. Gordon, et al.
Publicado: (2019)

Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus
por: Wen, Xiaolin, et al.
Publicado: (2017)

Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein
por: Gilman, Morgan S. A., et al.
Publicado: (2015)

Refining the Balance of Attenuation and Immunogenicity of Respiratory Syncytial Virus by Targeted Codon Deoptimization of Virulence Genes
por: Meng, Jia, et al.
Publicado: (2014)

Multiple co-circulating HIV-1 subtypes in the Middle East and North Africa
por: Rolland, Morgane, et al.
Publicado: (2015)

Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus
por: Sastry, Mallika, et al.
Publicado: (2017)

Ensuring HIV Data Availability, Transparency and Integrity in the MENA Region: Comment on "Improving the Quality and Quantity of HIV Data in the Middle East and North Africa: Key Challenges and Ways Forward"
por: Modjarrad, Kayvon, et al.
Publicado: (2017)

Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?
por: Modjarrad, Kayvon, et al.
Publicado: (2020)

Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion loop
por: Janus, Benjamin M., et al.
Publicado: (2018)

Structural basis for HCMV Pentamer recognition by neuropilin 2 and neutralizing antibodies
por: Wrapp, Daniel, et al.
Publicado: (2022)

Conservation of pregnancy-specific glycoprotein (PSG) N domains following independent expansions of the gene families in rodents and primates
por: McLellan, Andrew S, et al.
Publicado: (2005)

Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
por: Spindler, Nadja, et al.
Publicado: (2014)

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor
por: Roymans, Dirk, et al.
Publicado: (2017)

Alternative conformations of a major antigenic site on RSV F
por: Jones, Harrison G., et al.
Publicado: (2019)

Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies
por: Jones, Harrison G., et al.
Publicado: (2018)

Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development
por: Dussupt, Vincent, et al.
Publicado: (2021)

Structural basis for antibody recognition of vulnerable epitopes on Nipah virus F protein
por: Byrne, Patrick O., et al.
Publicado: (2023)

Breathing and tilting: mesoscale simulations illuminate influenza glycoprotein vulnerabilities
por: Casalino, Lorenzo, et al.
Publicado: (2022)

Breathing and Tilting: Mesoscale Simulations Illuminate Influenza Glycoprotein Vulnerabilities
por: Casalino, Lorenzo, et al.
Publicado: (2022)

Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks
por: Joyce, M. Gordon, et al.
Publicado: (2020)

Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein
por: Xie, Qingqing, et al.
Publicado: (2019)

Structure-Based Design of Prefusion-Stabilized Filovirus Glycoprotein Trimers
por: Rutten, Lucy, et al.
Publicado: (2020)

Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody neutralizing HCMV at a post-attachment step
por: Ye, Xiaohua, et al.
Publicado: (2020)

Mesoscale simulations illuminate the functional interplay and the vulnerabilities of influenza virus glycoproteins
por: Casalino, Lorenzo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o7vkrqqcmli0ocg83n32gditfi